Home

Royal Bank of Canada (RY)

117.76
+0.09 (0.08%)
NYSE · Last Trade: Apr 27th, 7:50 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Did Google Earnings Results Put Search Worries To Rest? Here's What Analysts Are Sayinginvestors.com
Google stock climbed on better-than-expected Q1 earnings and search ad revenue as management touted the new AI Overviews format.
Via Investor's Business Daily · April 25, 2025
Unpacking Q4 Earnings: RBC Bearings (NYSE:RBC) In The Context Of Other Engineered Components and Systems Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at RBC Bearings (NYSE:RBC) and the best and worst performers in the engineered components and systems industry.
Via StockStory · April 25, 2025
The Market and Fed Chair Powellfool.com
Fed independence brings stability, and markets love stability.
Via The Motley Fool · April 24, 2025
Google Earnings Due. Here's What Could Move Alphabet Stock.investors.com
Google stock has retreated 20% in 2025 heading into Alphabet's Q1 earnings report. Google's internet search business is still top of mind for investors amid the rise of generative artificial intelligence.
Via Investor's Business Daily · April 23, 2025
Danaher Makes A Bullish Move On 'Solid' Report, Promising Tariffs Planinvestors.com
The company's commentary on tariffs was a "pleasant surprise," according to one analyst.
Via Investor's Business Daily · April 22, 2025
Are Hospital Stocks At Risk Amid Medicaid Funding Fears? RBC Downplays Worries While Retail Eyes Q1 Resultsstocktwits.com
The Wall Street Journal highlighted UHS, THC and HCA as key beneficiaries of Medicaid supplemental payment programs that cost the federal government hundreds of billions.
Via Stocktwits · April 22, 2025
Chipotle Mexican Grill Q1 Preview: Retail Gets Bullish As Traders Eye Tariff Commentary, Expansion Plansstocktwits.com
The burrito chain has maintained that it will not increase the prices of its menu items and will offset higher input costs through automation and other initiatives.
Via Stocktwits · April 22, 2025
Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boostinvestors.com
The new FDA commissioner had a few key ideas for the agency in an interview with Megyn Kelly.
Via Investor's Business Daily · April 21, 2025
American Express' Solid Revenue, Spending Trends Drive Analyst Optimismbenzinga.com
RBC analyst maintains Outperform rating on American Express (AXP) with $310 price target. AXP reports strong Q1 2025 results, reaffirms revenue and EPS outlook.
Via Benzinga · April 21, 2025
Looking Into RBC Bearings's Recent Short Interestbenzinga.com
Via Benzinga · April 16, 2025
3 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decadefool.com
Consider buying these top-notch AI-powered stocks in the current market dip.
Via The Motley Fool · April 15, 2025
Bristol Myers Slumps On Heart Drug Failure — Taking Cytokinetics With Itinvestors.com
The companies are facing off with their heart drugs in a growing disease area.
Via Investor's Business Daily · April 14, 2025
We Asked Retail Traders Where Tesla's Next 20% Move Is — Most Say ‘Higher’ Despite Growing Short Intereststocktwits.com
Optimists think a bad earnings report is already priced in and hope CEO Elon Musk will soon announce his exit from Trump’s administration.
Via Stocktwits · April 14, 2025
Canadian Banks Ranking 2025 – Which Bank To Hold?talkmarkets.com
Whether you already hold one of these financial giants or are considering adding a bank to your portfolio, this will help you understand key strengths, weaknesses, and long-term investment potential.
Via Talk Markets · April 12, 2025
Energy Transfer: Tariff-Resistant Midstream Resilience
Energy Transfer showcases potential for investors through its record financial achievements, distribution yield, and strategic diversification efforts.
Via MarketBeat · April 11, 2025
Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.investors.com
From vaccines to fluoride and beef tallow, here's where Robert F. Kennedy Jr. is making changes to health care.
Via Investor's Business Daily · April 10, 2025
Wall Street Analysts Are Slashing Their Stock Market Forecasts. Here's What You Should Do, According to History.fool.com
Via The Motley Fool · April 9, 2025
CorMedix Stock Rises After Preliminary Q1 Results Exceeds Expectations: Retail’s Elatedstocktwits.com
The company expects quarterly adjusted earnings before interest, taxes, depreciation, and amortisation (EBITDA) to exceed $22.5 million once final numbers are reported, exceeding expectations of $14.78 million.
Via Stocktwits · April 8, 2025
Pacira Biosciences Stock Rises On Patent Litigation Settlement: Retail Sentiment Soarsstocktwits.com
RBC Capital opined that Pacira's settlement of litigation for generic Exparel, which provides some closure to over a year's worth of overhang and uncertainty for shares, is a win for the company and the Exparel franchise.
Via Stocktwits · April 8, 2025
5 Consumer Stocks That Hit 52-Week Lows Last Week On Trump's Tariff Shockwavesstocktwits.com
Retailers and consumer-facing companies are reeling more prominently as they fear the potential hike to consumer prices of their products will directly hurt sales.
Via Stocktwits · April 7, 2025
Woodside Energy In Spotlight After 40% Stake Sale In Louisiana LNG, Retail’s Bullishstocktwits.com
Stonepeak will provide $5.7 billion for the development of Louisiana LNG on an accelerated basis.
Via Stocktwits · April 7, 2025
Badger Meter Gets an Upgrade—2 Stocks That Could Follow
RBC analysts just boosted Badger Meter stock, but the broader theme behind this view might lead investors to other similar opportunities.
Via MarketBeat · April 4, 2025
Chewy Stock Is About as Cheap as It's Ever Been. 1 Thing to Know Before You Buy.fool.com
Via The Motley Fool · April 4, 2025
BlackBerry's QNX, Secure Comms Growth Weighed Down By Tariff Uncertainties, Government Election Shifts: Analystbenzinga.com
RBC Capital Markets analyst maintains BlackBerry with Sector Perform rating, lowers price target to $3.75 due to lower revenue and EBITDA guidance for fiscal 2026.
Via Benzinga · April 3, 2025
Sarepta Plunges After EMA Puts Gene Therapy Studies On Hold Following Teen's Deathinvestors.com
The holds are temporary while the teenager's death is under investigation.
Via Investor's Business Daily · April 3, 2025